Literature DB >> 19367123

Chemoprevention with phytochemicals targeting inducible nitric oxide synthase.

Akira Murakami.   

Abstract

A regulated low level of nitric oxide (NO) production in the body is essential for maintaining homeostasis (neuroprotection, vasorelaxation, etc.), though certain pathophysiological conditions associated with inflammation involve de novo synthesis of inducible NO synthase (iNOS) in immune cells, including macrophages. A large body of evidence indicates that many inflammatory diseases, such as colitis and gastritis, as well as many types of cancer, occur through sustained and elevated activation of this particular enzyme. The biochemical process of iNOS protein expression is tightly regulated and complex, in which the endotoxin lipopolysaccharide selectively binds to toll-like receptor 4 and thereby activates its adaptor protein MyD88, which in turn targets downstream proteins such as IRAK and TRAF6. This leads to functional activation of key protein kinases, including IkB kinases and mitogen-activated protein kinases (MAPKs), such as p38 MAPK, JNK1/2, and ERK1/2, all of which are involved in activating key transcription factors, including nuclear factor-kappaB and activator protein-1. In addition, the production of proinflammatory cytokines such as interferon-gamma and interleukin-12 potentiates iNOS induction in autocrine fashions. Meanwhile, an LPS-stimulated p38 MAPK pathway plays a pivotal role in the stabilization of iNOS mRNA, which has the AU-rich element in its 3'-untranslated region, for rapid NO production. Thus, suppression and/or inhibition of the above-mentioned signaling molecules may have a great potential for the prevention and treatment of inflammation-associated carcinogenesis. In fact, there have been numerous reports of phytochemicals found capable of targeting NO production by unique mechanisms, including polyphenols, terpenoids, and others. This review article briefly highlights the molecular mechanisms underlying endotoxin-induced iNOS expression in macrophages, and also focuses on promising natural agents that may be useful for anti-inflammation and anticarcinogenesis strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367123     DOI: 10.1159/000212751

Source DB:  PubMed          Journal:  Forum Nutr        ISSN: 0067-8198


  22 in total

1.  Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells.

Authors:  Xiaoqing Wang; Sheng-An Tang; Ran Wang; Yuling Qiu; Meihua Jin; Dexin Kong
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

2.  Increased growth inhibitory effects on human cancer cells and anti-inflammatory potency of shogaols from Zingiber officinale relative to gingerols.

Authors:  Shengmin Sang; Jungil Hong; Hou Wu; Jing Liu; Chung S Yang; Min-Hsiung Pan; Vladimir Badmaev; Chi-Tang Ho
Journal:  J Agric Food Chem       Date:  2009-11-25       Impact factor: 5.279

3.  Inhibitory effect of Jeju endemic seaweeds on the production of pro-inflammatory mediators in mouse macrophage cell line RAW 264.7.

Authors:  Eun-Jin Yang; Ji-Young Moon; Min-Jin Kim; Dong Sam Kim; Chan-Shick Kim; Wook Jae Lee; Nam Ho Lee; Chang-Gu Hyun
Journal:  J Zhejiang Univ Sci B       Date:  2010-05       Impact factor: 3.066

4.  Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats.

Authors:  Balaiya Velmurugan; Rana P Singh; Rajesh Agarwal; Chapla Agarwal
Journal:  Mol Carcinog       Date:  2010-07       Impact factor: 4.784

Review 5.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

6.  Silibinin prevents lung tumorigenesis in wild-type but not in iNOS-/- mice: potential of real-time micro-CT in lung cancer chemoprevention studies.

Authors:  Kumaraguruparan Ramasamy; Lori D Dwyer-Nield; Natalie J Serkova; Kendra M Hasebroock; Alpna Tyagi; Komal Raina; Rana P Singh; Alvin M Malkinson; Rajesh Agarwal
Journal:  Clin Cancer Res       Date:  2010-12-10       Impact factor: 12.531

7.  Inhibitory effects of the methylene chloride fraction of JP05 on the production of inflammatory mediators in LPS-activated BV2 microglia.

Authors:  Hyo Won Jung; Tae Woo Oh; Jin Ki Jung; Je-Hyun Lee; Gil Jo Shin; Yong-Ki Park
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

8.  Prophylactic effect of myricetin and apigenin against lipopolysaccharide-induced acute liver injury.

Authors:  Mehmet Berköz; Seda Ünal; Fahri Karayakar; Oruç Yunusoğlu; Ferbal Özkan-Yılmaz; Arzu Özlüer-Hunt; Ali Aslan
Journal:  Mol Biol Rep       Date:  2021-08-16       Impact factor: 2.316

9.  Phytate and Butyrate Differently Influence the Proliferation, Apoptosis and Survival Pathways in Human Cancer and Healthy Colonocytes.

Authors:  Lidia Hanna Markiewicz; Anna Maria Ogrodowczyk; Wiesław Wiczkowski; Barbara Wróblewska
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

10.  β-Lapachone, a substrate of NAD(P)H:quinone oxidoreductase, induces anti-inflammatory heme oxygenase-1 via AMP-activated protein kinase activation in RAW264.7 macrophages.

Authors:  Seung Jae Byun; Young Son; Baik Hwan Cho; Hun-Taeg Chung; Hyun-Ock Pae
Journal:  J Clin Biochem Nutr       Date:  2012-12-15       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.